120 related articles for article (PubMed ID: 38728186)
21. Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition.
Reijs BLR; Ramakers IHGB; Elias-Sonnenschein L; Teunissen CE; Koel-Simmelink M; Tsolaki M; Wahlund LO; Waldemar G; Hausner L; Johannsen P; Vanderstichele H; Verhey F; Devanand DP; Visser PJ
J Alzheimers Dis; 2017; 60(3):1025-1034. PubMed ID: 28984603
[TBL] [Abstract][Full Text] [Related]
22. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
[TBL] [Abstract][Full Text] [Related]
23. Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects.
Toledo JB; Zetterberg H; van Harten AC; Glodzik L; Martinez-Lage P; Bocchio-Chiavetto L; Rami L; Hansson O; Sperling R; Engelborghs S; Osorio RS; Vanderstichele H; Vandijck M; Hampel H; Teipl S; Moghekar A; Albert M; Hu WT; Monge Argilés JA; Gorostidi A; Teunissen CE; De Deyn PP; Hyman BT; Molinuevo JL; Frisoni GB; Linazasoro G; de Leon MJ; van der Flier WM; Scheltens P; Blennow K; Shaw LM; Trojanowski JQ;
Brain; 2015 Sep; 138(Pt 9):2701-15. PubMed ID: 26220940
[TBL] [Abstract][Full Text] [Related]
24. Relations between personality changes and cerebrospinal fluid biomarkers of Alzheimer's disease pathology.
Tautvydaitė D; Antonietti JP; Henry H; von Gunten A; Popp J
J Psychiatr Res; 2017 Jul; 90():12-20. PubMed ID: 28213293
[TBL] [Abstract][Full Text] [Related]
25. Positive Association Between Cognitive Function and Cerebrospinal Fluid Orexin A Levels in Alzheimer's Disease.
Shimizu S; Takenoshita N; Inagawa Y; Tsugawa A; Hirose D; Kaneko Y; Ogawa Y; Serisawa S; Sakurai S; Hirao K; Kanetaka H; Kanbayashi T; Imanishi A; Sakurai H; Hanyu H
J Alzheimers Dis; 2020; 73(1):117-123. PubMed ID: 31744010
[TBL] [Abstract][Full Text] [Related]
26. Cholesterol metabolites and plant sterols in cerebrospinal fluid are associated with Alzheimer's cerebral pathology and clinical disease progression.
Jahn T; Clark C; Kerksiek A; Lewczuk P; Lütjohann D; Popp J
J Steroid Biochem Mol Biol; 2021 Jan; 205():105785. PubMed ID: 33171206
[TBL] [Abstract][Full Text] [Related]
27. Associations between cardiometabolic multimorbidity and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact adults: the CABLE study.
Li QY; Hu HY; Zhang GW; Hu H; Ou YN; Huang LY; Wang AY; Gao PY; Ma LY; Tan L; Yu JT
Alzheimers Res Ther; 2024 Feb; 16(1):28. PubMed ID: 38321520
[TBL] [Abstract][Full Text] [Related]
28. A data-driven model of biomarker changes in sporadic Alzheimer's disease.
Young AL; Oxtoby NP; Daga P; Cash DM; Fox NC; Ourselin S; Schott JM; Alexander DC;
Brain; 2014 Sep; 137(Pt 9):2564-77. PubMed ID: 25012224
[TBL] [Abstract][Full Text] [Related]
29. Cognitive Dispersion Is Not Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Results from the European Prevention of Alzheimer's Dementia (EPAD) v500.0 Cohort.
Watermeyer T; Marroig A; Ritchie CW; Ritchie K; Blennow K; Muniz-Terrera G;
J Alzheimers Dis; 2020; 78(1):185-194. PubMed ID: 32955462
[TBL] [Abstract][Full Text] [Related]
30. Association of Cerebrospinal Fluid S100B Protein with Core Biomarkers and Cognitive Deficits in Prodromal and Mild Alzheimer's Disease.
Christl J; Verhülsdonk S; Pessanha F; Menge T; Seitz RJ; Kujovic M; Höft B; Supprian T; Lange-Asschenfeldt C
J Alzheimers Dis; 2019; 72(4):1119-1127. PubMed ID: 31683478
[TBL] [Abstract][Full Text] [Related]
31. Memory Correlates of Alzheimer's Disease Cerebrospinal Fluid Markers: A Longitudinal Cohort Study.
Reijs BLR; Ramakers IHGB; Köhler S; Teunissen CE; Koel-Simmelink M; Nathan PJ; Tsolaki M; Wahlund LO; Waldemar G; Hausner L; Vandenberghe R; Johannsen P; Blackwell A; Vanderstichele H; Verhey F; Visser PJ
J Alzheimers Dis; 2017; 60(3):1119-1128. PubMed ID: 28984585
[TBL] [Abstract][Full Text] [Related]
32. Gait Disturbances are Associated with Increased Cognitive Impairment and Cerebrospinal Fluid Tau Levels in a Memory Clinic Cohort.
Muurling M; Rhodius-Meester HFM; Pärkkä J; van Gils M; Frederiksen KS; Bruun M; Hasselbalch SG; Soininen H; Herukka SK; Hallikainen M; Teunissen CE; Visser PJ; Scheltens P; van der Flier WM; Mattila J; Lötjönen J; de Boer C
J Alzheimers Dis; 2020; 76(3):1061-1070. PubMed ID: 32597806
[TBL] [Abstract][Full Text] [Related]
33. Correlation between CSF biomarkers of Alzheimer's disease and global cognition in a psychogeriatric clinic cohort.
Radanovic M; Oshiro CA; Freitas TQ; Talib LL; Forlenza OV
Braz J Psychiatry; 2019; 41(6):479-484. PubMed ID: 31166546
[TBL] [Abstract][Full Text] [Related]
34. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
[TBL] [Abstract][Full Text] [Related]
35. Tau Pathologies Mediate the Associations of Vascular Risk Burden with Cognitive Impairments in Non-demented Elders: The CABLE Study.
Yu GX; Ou YN; Bi YL; Ma YH; Hu H; Wang ZT; Hou XH; Xu W; Tan L; Yu JT
J Prev Alzheimers Dis; 2022; 9(1):136-143. PubMed ID: 35098984
[TBL] [Abstract][Full Text] [Related]
36. Associations of Physical Activity with Alzheimer's Disease Pathologies and Cognition: The CABLE Study.
Zhong S; Zhao B; Ma YH; Sun Y; Zhao YL; Liu WH; Ou YN; Dong Q; Tan L; Yu JT
J Alzheimers Dis; 2022; 89(2):483-492. PubMed ID: 35871345
[TBL] [Abstract][Full Text] [Related]
37. Montreal Cognitive Assessment in Mild Cognitive Impairment: Relationship with Cerebrospinal Fluid Biomarkers and Conversion to Dementia.
Bernardes C; Lima M; Duro D; Silva-Spínola A; Durães J; Tábuas-Pereira M; Baldeiras I; Freitas S; Santana I
J Alzheimers Dis; 2023; 96(3):1173-1182. PubMed ID: 37927268
[TBL] [Abstract][Full Text] [Related]
38. Sexually Dimorphic Association of Circulating Plasminogen Activator Inhibitor-1 Levels and Body Mass Index with Cerebrospinal Fluid Biomarkers of Alzheimer's Pathology in Preclinical Alzheimer's Disease.
Eruysal E; Ravdin L; Zhang C; Kamel H; Iadecola C; Ishii M
J Alzheimers Dis; 2023; 91(3):1073-1083. PubMed ID: 36565112
[TBL] [Abstract][Full Text] [Related]
39. Relationship between cerebrospinal fluid biomarkers of Alzheimer's disease and cognition in cognitively normal older adults.
Pettigrew C; Soldan A; Moghekar A; Wang MC; Gross AL; O'Brien R; Albert M
Neuropsychologia; 2015 Nov; 78():63-72. PubMed ID: 26394023
[TBL] [Abstract][Full Text] [Related]
40. Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.
Abdelnour C; van Steenoven I; Londos E; Blanc F; Auestad B; Kramberger MG; Zetterberg H; Mollenhauer B; Boada M; Aarsland D;
Mov Disord; 2016 Aug; 31(8):1203-8. PubMed ID: 27296778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
